AI assistant
Sending…
RESMED INC — Director's Dealing 2024
Mar 7, 2024
30071_dirs_2024-03-06_60f14bbd-ccec-4fd3-84fd-991394f5ed75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-03-04
Reporting Person: Rider Michael J (Global General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-04 | ResMed Common Stock | S | 81 | $180.00 | Disposed | 6607 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2023.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29